Evidence map›Paper›PMID 36578630›Full record

ArticleERJ open research2022

Targeted lung denervation modulates the mucosal epithelial transcriptome in COPD.

Karthi Srikanthan, Loes Kistemaker, Dirk-Jan Slebos, Wolfgang Gesierich, Kaid Darwiche, Peter Bonta, Gaetan Deslee, Pallav Shah, Reinoud Gosens

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Genomic crosstalk between carbachol, a muscarinic receptor agonist, and the long-acting βThe Journal of pharmacology and experimental therapeutics · 2025
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 4 countries.

Karthi SrikanthanRoyal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College, London, UK.ORCID https://orcid.org/0000-0002-6751-5020
Loes KistemakerAquilo BV, Groningen, The Netherlands.
Dirk-Jan SlebosUniversity Medical Center Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-9555-3422
Wolfgang GesierichAsklepios-Fachkliniken Munchen Gauting, Gauting, Germany.ORCID https://orcid.org/0000-0001-6707-6358
Kaid DarwicheDepartment for Interventional Pneumology, Ruhrlandklinik - University Medicine, Essen, Germany.ORCID https://orcid.org/0000-0003-0681-1325
Peter BontaAcademic Medical Centre, Amsterdam, The Netherlands.
Gaetan DesleeDepartment of Pulmonary Medicine, INSERM UMRS 1250, CHU of Reims, Reims, France.
Pallav ShahRoyal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College, London, UK.ORCID https://orcid.org/0000-0002-9052-4638
Reinoud GosensDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Royal Brompton & Harefield NHS Foundation Trust · GBAmsterdam UMC Location University of Amsterdam · NLAsklepios Fachkliniken München-Gauting · DEDialyse Centrum Groningen · NLInserm · FRRuhrlandklinik · DEUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36578630
PMCPMC9793243
OpenAlexW4294000709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.